AB168. Expression and clinical significance of CCAT2 in renal cell carcinoma and bladder cancer
Printed Abstracts

AB168. Expression and clinical significance of CCAT2 in renal cell carcinoma and bladder cancer

Song Wu, Wei Lu

Shenzhen Luohu People’s Hospital, Shenzhen 518001, China


Objective: To research the expression of CCAT2 in renal cell carcinoma (RCC), bladder cancer and paired normal tumor-adjacent tissues and investigate the correlations between expression of CCAT2 and clinicopathologic characteristics for further study of the role of CCAT2 in RCC and bladder cancer.

Methods: Total RNA isolated from 40 RCC and 37 bladder cancer tissues and paired normal tumor-adjacent normal tissues which random selected from specimen bank was used for obtaining cDNA by performing reverse transcription. Using real-time PCR (RT-PCR) to detect the expression of CCAT2 in specimen, then using statistical method to analysis the relationships between the expression of CCAT2 and clinicopathologic characteristic.

Results: The expression of CCAT2 in RCC tissues was significantly lower than in paired normal tumor-adjacent tissues (P<0.01), with 33 cases (82.5%) showing down-regulation of CCAT2. While the expression of CCAT2 in bladder cancer tissues was significantly higher than in paired normal tumor-adjacent tissues (P<0.01),with 31 cases (83.8%) showing up-regulation of CCAT2.No relationships were found between the expression of CCAT2 and patients’ age, gender, histology, TNM stage or AJCC stage.

Conclusion: CCAT2 is up-regulated in bladder cancer and down-regulated in RCC, indicating it may participate in the tumorigenesis and development of RCC and bladder cancer and be used as a tumor marker.

Keywords: CCAT2; renal cell cancer; bladder cancer; clinical significance


doi: 10.21037/tau.2016.s168


Cite this abstract as: Wu S, Lu W. Expression and clinical significance of CCAT2 in renal cell carcinoma and bladder cancer. Transl Androl Urol 2016;5(Suppl 1):AB168. doi: 10.21037/tau.2016.s168

Download Citation